Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ITO, T.
Right arrow Articles by YAMAKIDO, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ITO, T.
Right arrow Articles by YAMAKIDO, M.
J Am Soc Nephrol 11:1969-1979, 2000
© 2000 American Society of Nephrology

Effect of Glucose on Intercellular Junctions of Cultured Human Peritoneal Mesothelial Cells

TAKAFUMI ITO*, NORIAKI YORIOKA*, MASAO YAMAMOTO{dagger}, KATSUKO KATAOKA{dagger} and MICHIO YAMAKIDO*

* Department of Internal Medicine II, Hiroshima University School of Medicine, Hiroshima, Japan.
{dagger} Department of Anatomy II, Hiroshima University School of Medicine, Hiroshima, Japan.

Correspondence to Dr. Noriaki Yorioka, Department of Internal Medicine II, Hiroshima University School of Medicine, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Phone: +81-82-257-5196, Fax: +81-82-255-7360; E-mail: nyorioka{at}mcai.med.hiroshima-u.ac.jp


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Abstract. During continuous ambulatory peritoneal dialysis, the peritoneum is directly and continuously exposed to unphysiologic peritoneal dialysis fluid; the resulting mesothelial damage has been suggested to cause loss of ultrafiltration and dialysis efficacy. The present study investigated the effect of a high glucose concentration on cultured human peritoneal mesothelial cells to clarify the cause of decreased dialysis efficacy during prolonged peritoneal dialysis. High glucose caused a concentration-dependent decrease in cell proliferation, damage to the intercellular junctions, and excess production of transforming growth factor-ß (TGF-ß). The levels of intercellular junctional proteins (ZO-1, E-cadherin, and ß-catenin) were decreased, and immuno-staining by anti—ZO-1 and anti— ß-catenin antibodies became weaker and often discontinuous along the cell contour. Mannitol had similar but weaker effects at the same osmolality, and an anti—TGF-ß neutralizing antibody reduced the effects of high glucose. Therefore, these effects were induced not only by glucose itself but also by hyperosmolality and by a glucose-induced increase of TGF-ß. These findings suggest that the peritoneal mesothelium is damaged by prolonged peritoneal dialysis using high glucose dialysate and that impairment of the intercellular junctions of peritoneal mesothelial cells by high glucose dialysate induces peritoneal hyperpermeability and a progressive reduction in dialysis efficacy.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Continuous ambulatory peritoneal dialysis (CAPD) has been used for two decades as an adequate and effective treatment for end-stage renal disease. In patients with CAPD, the peritoneum functions as a dialyzer and forms the permeability barrier across which ultrafiltration and diffusion occur. Progressive loss of dialysis efficacy is a major complication of long-term CAPD. It has been attributed to the direct and continuous exposure of the peritoneum to peritoneal dialysis fluid, which is always unphysiologic because of its low pH, high glucose content, and hyperosmolality (1). Previous studies have shown that CAPD is associated with morphologic changes of mesothelial cells, such as loss of the microvilli, widening of the intercellular spaces, and exfoliation (2,3,4,5). Also, the mesothelium fails to regenerate properly after a long period of dialysis, so the peritoneum becomes denuded of mesothelial cells and undergoes fibrotic thickening (3,6,7). Damage to mesothelial cells is considered to be the primary cause of the decline in ultrafiltration and dialysis efficacy, which might be responsible for the relatively high failure rate of CAPD (8,9).

Mesothelial cells are reported to possess several different types of intercellular junctions, including tight junctions, adherens junctions, desmosomes, and gap junctions (10,11,12). Tight junctions selectively regulate the passage of molecules through the paracellular pathway (gate function) and also separate molecules in the apical and basolateral plasma membrane domains (fence function) (13). Adherens junctions form a continuous adhesion belt that connects the cytoskeletal elements of one mesothelial cell to those of another.

Mesothelial cells have the capacity to produce a variety of matrix macromolecules. Synthesis of the extracellular matrix is regulated by several growth factors, among which transforming growth factor-ß (TGF-ß) is the critical one (14). TGF-ß has been detected in CAPD effluent (15), peritoneal mesothelial cells are known to synthesize this growth factor (16), and a high glucose concentration enhances TGF-ß gene expression by cultured human peritoneal mesothelial cells (HPMC) (17,18,19,20,21). Moreover, it has been reported that TGF-ß inhibits mesothelial cell growth and significantly increases the permeability of mesothelial cell monolayers for FITC-labeled albumin (22). Both of these effects of TGF-ß are completely blocked by an anti—TGF-ß neutralizing antibody (17,22).

Little is known about the effects of high glucose levels and TGF-ß in peritoneal dialysis fluid on the intercellular junctions of mesothelial cells. Accordingly, this study investigated the effect of a high glucose concentration on the intercellular junctions and on TGF-ß production by HPMC, as well as the effect of TGF-ß and an anti—TGF-ß neutralizing antibody.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Isolation and Culture of HPMC
HPMC were isolated according to the method of Stylianou et al. (23). Briefly, a piece of human omentum (approximately 3 to 5 cm 2) obtained during abdominal surgery was washed three times with sterile phosphate-buffered saline (PBS) (pH 7.2; Nissui Pharmaceutical Co., Tokyo, Japan) and then incubated for 15 to 20 min at 37°C with shaking in PBS containing 0.125% (wt/vol) trypsin-0.01% (wt/vol) ethylenediaminetetraacetate solution (Life Technologies, Grand Island, NY). After incubation, the omental tissue was removed, the solution containing free mesothelial cells was centrifuged (100 g for 10 min at 4°C), and the supernatant was discarded. Then the cell pellet was washed once and suspended in M199 culture medium (Life Technologies) supplemented with 10% fetal calf serum (FCS; vol/vol) (Mitsubishi Kasei Corp., Tokyo, Japan), 100 U/ml penicillin (Life Technologies), 100 µg/ml streptomycin (Life Technologies), and 2 mM L-glutamine (Life Technologies). After being seeded into 75-cm 2 tissue culture flasks coated with rat type I collagen (Becton Dickinson, Bedford, MA), the cells were grown in the same medium at 37°C under a 5% CO2 atmosphere in a humidified incubator. The medium was changed at 24 h after seeding and then once every 3 d. Cells from the first to third passages were used.

Harvesting of the omentum was permitted by the Medical Ethics Committee of Hiroshima University School of Medicine, and informed consent was obtained from each patient.

Identification of Mesothelial Cells
The cultured cells were examined under an inverted phase contrast microscope. In addition, immunostaining was performed with monoclonal antibodies for human cytokeratin (Dako, Kyoto, Japan), vimentin (Dako), desmin (Dako), and human Factor VIII (Dako). Visualization was done with a Texas red-labeled secondary antibody (Jackson Immuno Research Laboratories, West Grove, PA).

Culture Media
Fifteen different culture media were tested. Standard M199 medium containing 1.0% FCS (vol/vol), 100 U/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine was used as the control (glucose concentration, 5.6 mM). In the experimental cultures, M199 medium was supplemented with D-glucose (Kanto Chemical Co., Inc., Tokyo, Japan), D-mannitol (Sigma Chemical Co., St. Louis, MO) at various concentrations (75 mM [1.35%], 140 mM [2.5%], and 222 mM [4.0%]), or with recombinant TGF-ß1 (R&D Systems Inc., Minneapolis, MN) at various concentrations (100, 500, and 1000 pg/ml). In some experiments, the 222 mM D-glucose or 500 pg/ml TGF-ß1 media also contained various concentrations of an anti—TGF-ß neutralizing antibody (1, 4, and 10 µg/ml; R&D Systems). To assess the effect of blocking TGF- ß activity, media containing TGF-ß1 were preincubated with this neutralizing antibody for 2 h at room temperature. All media were sterilized by filtration (0.22 µm, Millex-GV, Millipore Corp., Bedford, MA) and then stored at 4°C for use within 3 d.

Assay of Cell Proliferation
Cells were grown to confluent monolayers in culture flasks, harvested with 0.25% (wt/vol) trypsin-0.02% (wt/vol) ethylenediaminetetraacetate in PBS, and resuspended in fresh M199 medium containing 10% FCS. Then the cells (2 x 104/100 µl per well) were seeded into 96-well tissue culture plates coated with rat type I collagen (Becton Dickinson). After the cultures were confirmed to be subconfluent by microscopy, cells were washed twice with PBS and the medium was replaced with 100 µl of fresh standard medium. The cells were then cultured for an additional 48 h to allow them to become confluent and quiescent, washed twice with PBS, and used in the following experiments. Cell viability was assessed using a cell counting kit (Dojindo, Kumamoto, Japan) that used a colorimetric assay based on cleavage of the water-soluble tetrazolium salt WST-1 [2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt] to a formazan dye by mitochondrial dehydrogenase in viable cells (24,25). Test solutions (100 µl/well) were added to confluent HPMC and incubated for 6, 12, 24, or 48 h, with the WST-1 solution (5 mM WST-1, 20 mM HEPES, and 0.2 mM 1-methoxy-5-methylphenazinium methylsulfate) being added at 10 µl/well for the last 4 h. The absorbance was determined using an enzyme-linked immunosorbent assay reader (SLT Lab Instruments, Salzburg, Austria) at an excitation wavelength of 420 nm and an emission wavelength of 630 nm.

Immunostaining of Intercellular Junction Proteins
Cells were cultured on 24 x 24-mm glass coverslips coated with porcine type I collagen (Nitta Gelatin Co., Osaka, Japan) in 60-mm culture dishes (Becton Dickinson). After cultures were shown to be subconfluent by microscopy, cells were washed twice with PBS, the medium was replaced with a fresh standard medium, and the cells were incubated for another 48 h to reach confluence. After the cells were washed twice more with PBS, they were then cultured for 48 h in the test media. Next, the cells were fixed in cold acetone/methanol at -20°C for 5 min, rehydrated in PBS, and blocked for 1 h in PBS containing 20% Block Ace (Dainippon Seiyaku Co. Ltd., Tokyo, Japan). This was followed by overnight incubation with a primary antibody at 4°C. The primary antibodies used were a rabbit antibody for ZO-1 (a tight junction protein; Zymed Laboratories Inc., San Francisco, CA) at a dilution of 1:100 and a mouse antibody for ß-catenin (an adherens junction—associated protein; Zymed Laboratories Inc.) at 1:100. After incubation with the primary antibody, cells were washed five times with PBS. Then an appropriate secondary antibody (1:100) labeled with FITC (Dako) or Texas red (Jackson Immuno Research Laboratories) was applied for 1 h at room temperature, and the cells were again washed five times with PBS. Stained specimens were examined under a confocal laser scanning microscope (TCS-NT, Leitz, Weitzlar, Germany).

Western Blot Analysis of Intercellular Junction Proteins
Cells were cultured in 100-mm dishes. After the cultures were confirmed to be subconfluent by microscopy, the cells were washed twice with PBS, the medium was replaced with a fresh standard medium, and the cells were incubated for an additional 48 h to reach confluence. After the cells were washed twice with PBS, they were cultured for 48 h in the test media. Next, cells were again washed twice with PBS and were lysed in a culture dish by adding 900 µl of TRIZOL® Reagent (Life Technologies). Cellular protein was isolated, and 20 µg of total protein, as measured with the BCA protein assay (Pierce, Rockford, IL), was dissolved in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and boiled for 3 min. Samples were subjected to SDS-PAGE on 8% gels and then transferred to PVDF membranes (Millipore Corp.). The membranes were blocked for 1 h at room temperature in PBS containing 1% Tween 20 (Katayama Chemical, Osaka, Japan) and 20% Block Ace (PBST-20% Block Ace) and were incubated for 1 h with a primary antibody:rabbit anti-ZO-1 (1:5000), mouse anti—E-cadherin (Transduction Laboratories, Lexington, KY; 1:5000), or mouse anti—ß-catenin (1:10,000). Then the membranes were washed (once for 15 min and twice for 5 min) in PBST-20% Block Ace and incubated for 1 h at room temperature with an appropriate secondary antibody (1:5000) labeled with horseradish peroxidase (Amersham Pharmacia Biotech, Buckinghamshire, England). After incubation, the membranes were washed again (once for 15 min and four times for 5 min), and the reaction products were detected by chemiluminescence (Amersham Pharmacia Biotech). The intensity of each band was estimated using NIH image software (version 1.61).

Assay of TGF-ß1 Production by HPMC
Supernatants were collected after the cells were cultured for 48 h with various glucose or mannitol concentrations in 12-well tissue culture plates (Becton Dickinson). The TGF-ß1 level in culture supernatants was determined with an enzyme-linked immunosorbent assay kit (R&D Systems Inc.) and was normalized for the number of cells. All experiments were performed in duplicate. We also determined the TGF-ß1 level in each test medium without HPMC.

Statistical Analyses
Results are expressed as the mean ± SD of three experiments, each performed in duplicate. Data were examined using ANOVA (Fisher's protected least significant difference test), and differences were considered significant at P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Identification of HPMC
The cultured cells were identified as mesothelial cells by their typical cobblestone appearance at confluence, positive staining for cytokeratin and vimentin, and negative staining for desmin and Factor VIII.

Standard Curve of WST-1 Colorimetric Assay
The absorbance showed a linear correlation with the number of cells (from 5.0 x 103 to 3.0 x 104 per well) in a 96-well culture plate (r = 0.966, P < 0.0001). Therefore, the number of cells was calculated from the absorbance (Figure 1).



View larger version (12K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Standard curve of the cell counting kit (WST-1 colorimetric assay). The absorbance showed a good linear correlation with the number of cells at an excitation wavelength of 420 nm (n = 4, r = 0.966, P < 0.0001).

 

Proliferation of HPMC
There was a concentration-dependent decrease in cell proliferation after culture for 48 h as the glucose concentration increased from 5.6 mM to 222 mM (Figure 2). High glucose (222 mM) significantly depressed cell proliferation after 48 h when compared with the lowest glucose concentration tested (5.6 mM). Similar results were also seen after 6, 12, and 24 h of incubation. Mannitol also decreased cell proliferation in a concentration-dependent manner, but the extent of inhibition was less than that caused by glucose at the same osmolality. There was a significant difference in cell proliferation after 48 h of incubation with glucose or mannitol at 222 mM (P < 0.01).



View larger version (49K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Effects of culture for 48 h with media containing various concentrations of glucose (G) or mannitol (M). A medium containing 5.6 mM glucose (pH 7.3) was used as the control. Results are mean ± SD of three experiments, each performed in duplicate. The number of cells decreased as the concentration of glucose or mannitol increased (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).

 

Immunostaining
In control cultures, the cell contour was clearly outlined by fluorescence immunostaining for ZO-1 and ß-catenin. The contour immunofluorescence of both ZO-1 and ß-catenin decreased and became discontinuous after incubation with glucose, and this effect was concentration-dependent (Figures 3 and 4). In addition, immunofluorescence for ß-catenin was markedly increased in the perinuclear region. However, manitol caused only a slight decrease in the expression of these proteins, and there was no discontinuity of staining along the cell contour. All of these changes were more marked after 48 h of culture.



View larger version (50K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Immunocytochemistry for ZO-1 after culture in various media. (a) Control, (b) 75 mM glucose, (c) 140 mM glucose, (d) 222 mM glucose, (e) 75 mM mannitol, (f) 140 mM mannitol, (g) 222 mM mannitol. Bar, 10 µm. The cell contour is outlined by continuous fluorescence in the control (a). The fluorescence becomes weaker and discontinuous (arrows) with increasing concentrations of glucose (b, c, d) and mannitol (e, f, g).

 


View larger version (30K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 4. Immunocytochemistry for ß-catenin after culture in various media. (a) Control, (b) 75 mM glucose, (c) 140 mM glucose, (d) 222 mM glucose, (e) 75 mM mannitol, (f) 140 mM mannitol, (g) 222 mM mannitol. Bar, 10 µm. At 222 mM glucose, the fluorescence along the cell contour almost disappeared, but the perinuclear regions show marked fluorescence (arrows). Mannitol causes less marked changes.

 

Western Blot Analysis
High glucose (222 mM) decreased the levels of ZO-1, E-cadherin, and ß-catenin (Figure 5). Mannitol also decreased ZO-1 and ß-catenin, but the extent of the change was smaller than with glucose at the same osmolality. These changes all were more marked after 48 h of culture.



View larger version (21K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 5. (A) Western blot analysis of intercellular junction—associated proteins (ZO-1, E-cadherin, and ß-catenin) after human peritoneal mesothelial cells (HPMC) were cultured in medium containing 5.6 mM glucose (control), 222 mM glucose (G 222 mM), or 222 mM mannitol (M 222 mM). (B) All three proteins were markedly reduced by G 222 mM, whereas M 222 mM had less effect. Data show the mean values of three experiments. The control (5.6 mM glucose) value was assumed to be 100%. *P < 0.0001 versus control (5.6 mM glucose).

 

TGF-ß1 Production
In control cultures, confluent HPMC were shown to constitutively release TGF-ß1, and the mean (± SD) TGF-ß1 level was 15.6 ± 0.4 pg/ml per 104 cells. The highest TGF-ß1 concentration detected was 51.9 ± 2.6 pg/ml per 104 cells after culture with high glucose (222 mM). However, the TGF-ß1 concentration was under the detection limit of the assay in media without HPMC. Induction of TGF-ß1 secretion by glucose or mannitol was concentration dependent and was greater with glucose than with mannitol at the same osmolality (140 mM; P < 0.01, 222 mM; P < 0.0001) (Figure 6).



View larger version (35K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 6. Transforming growth factor-ß1 (TGF-ß1) concentration in the culture supernatant after incubation of HPMC with various concentrations of glucose (G) or mannitol (M). Medium containing 5.6 mM glucose (pH 7.3) was used as the control. Results are mean ± SD of three experiments, each performed in duplicate. Glucose caused TGF-ß1 to increase markedly, whereas mannitol increased TGF- ß1 only moderately (**P < 0.01, ****P < 0.0001). In media without HPMC, the TGF-ß1 concentration was always under the detection limit of the assay.

 

Effect of Recombinant TGF-ß1
There was a concentration-dependent decrease of cell proliferation after culture for 48 h with recombinant TGF-ß1 at concentrations from 100 to 1000 pg/ml (Figure 7). Contour immunofluorescence for both ZO-1 and ß-catenin also decreased and became irregular in a concentration-dependent manner (Figure 8). Furthermore, culture with recombinant TGF-ß1 decreased the levels of ZO-1, E-cadherin, and ß-catenin, as shown by Western blotting (Figure 9).



View larger version (20K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 7. Effect of culture of HPMC for 48 h in media containing various concentrations of recombinant TGF-ß1. Medium containing 5.6 mM glucose (pH 7.3) was used as the control. Results are mean ± SD of three experiments, each performed in duplicate. The number of cells decreased with an increasing concentration of recombinant TGF-ß1 (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).

 


View larger version (65K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 8. Immunocytochemistry for ZO-1 (a through d) and ß-catenin (e through h) after culture with TGF-ß1. (a, e) Control, (b, f) 100 pg/ml recombinant TGF-ß1, (c, g) 500 pg/ml recombinant TGF-ß1, (d, h) 1000 pg/ml recombinant TGF-ß1. Bar, 10 µm. The cell contour is outlined by continuous fluorescence in the control (a, e). Fluorescence decreases and becomes irregular as the TGF- ß1 concentration increases.

 


View larger version (20K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 9. (A) Western blot analysis of intercellular junction—associated proteins (ZO-1, E-cadherin, and ß-catenin) after HPMC were cultured with 100 pg/ml (T100), 500 pg/ml (T500), or 1000 pg/ml (T1000) of recombinant TGF- ß1. (B) ZO-1 and E-cadherin were reduced in a concentration-dependent manner. ß-catenin was also reduced, but no significant difference was observed between each concentration of TGF- ß1. Data show the mean values of three experiments. The control (5.6 mM glucose) value was assumed to be 100% (*P < 0.0001 versus control).

 

Effect of the Anti—TGF-ß Neutralizing Antibody
Addition of the anti—TGF-ß neutralizing antibody to cultures increased the proliferation of HPMC in the presence of 222 mM D-glucose or 500 pg/ml recombinant TGF-ß1 (Figure 10). We tested the neutralizing antibody at 1, 4, and 10 µg/ml and found that it was most effective at 4 µg/ml. It also increased the contour immunostaining for ZO-1 and ß-catenin in cells incubated with 222 mM D-glucose (Figure 11) or 500 pg/ml recombinant TGF-ß1 (Figure 12). Western blotting confirmed that the levels of ZO-1, E-cadherin, and ß-catenin were increased by the neutralizing antibody (Figures 13 and 14).



View larger version (62K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 10. (A) Effect on the proliferation of HPMC after culture for 48 h in media containing high concentration of glucose (G 222 mM) with or without an anti—TGF-ß neutralizing antibody (ATA, the numbers show the concentration in µg/ml). Medium containing 5.6 mM glucose (pH 7.3) was used as the normal control. Results are mean ± SD of three experiments, each performed in duplicate (*P < 0.05, **P < 0.01, ****P < 0.0001). The neutralizing antibody significantly increased the number of cells compared with culture with 222 mM glucose (G 222 mM) alone. (B) Effect on the proliferation of HPMC after culture for 48 h in media containing 500 pg/ml recombinant TGF- ß1 with or without an anti-TGF-ß neutralizing antibody (ATA, the numbers show the concentration in µg/ml). Medium containing 5.6 mM glucose (pH 7.3) was used as the normal control. Results are mean ± SD of three experiments, each performed in duplicate (**P < 0.01, ***P < 0.001, ****P < 0.0001). The neutralizing antibody, especially at 4 µg/ml, significantly increased the number of cells compared with culture with 500 pg/ml of recombinant TGF- ß1 (T500) alone.

 


View larger version (41K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 11. Immunocytochemistry for ZO-1 (a, b) and ß-catenin (c, d) after culture of HPMC in medium containing 222 mM glucose alone (a, c) or 222 mM glucose plus an anti—TGF-ß neutralizing antibody (4 µg/ml; b, d). Bar, 10 µm. The neutralizing antibody increased immunostaining of the cell contour.

 


View larger version (104K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 12. Immunocytochemistry for ZO-1 (a, b) and ß-catenin (c, d) after culture in medium containing 500 pg/ml recombinant TGF- ß1 alone (a, c) or TGF-ß1 plus an anti-TGF-ß neutralizing antibody (4 µg/ml) (b, d). Bar, 10 µm. The neutralizing antibody increased immunostaining of the cell contour.

 


View larger version (22K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 13. (A) Western blot analysis of intercellular junction—associated proteins (ZO-1, E-cadherin, and ß-catenin) after culture of HPMC in medium containing 222 mM glucose alone (G 222 mM) or 222 mM glucose plus an anti—TGF-ß neutralizing antibody (ATA, the numbers show the concentration in µg/ml). (B) The neutralizing antibody increased all three proteins, especially at 4 µg/ml. Data show the mean values of three experiments. The control (5.6 mM glucose) value was assumed to be 100% (*P < 0.0001 versus 222 mM glucose).

 


View larger version (23K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 14. (A) Western blot analysis of intercellular junction—associated proteins (ZO-1, E-cadherin, and ß-catenin) after culture of HPMC in medium containing 500 pg/ml recombinant TGF- ß1 alone (T500) or T500 plus an anti—TGF-ß neutralizing antibody (ATA, the numbers show the concentration in µg/ml). (B) The neutralizing antibody increased all three proteins, with ZO-1 and E-cadherin returning to control levels. Data show the mean values of three experiments. The control (5.6 mM glucose) value was assumed to be 100% (*P < 0.0001 versus 500 pg/ml recombinant TGF- ß1).

 

Although cell proliferation and the expression of intercellular junctional proteins both were increased in cultures with high glucose (222 mM), they did not reach control levels. Thus, the blocking effect of the neutralizing antibody on the actions of 222 mM glucose was weaker than that against 500 pg/ml of recombinant TGF-ß1.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
CAPD is a well-accepted treatment for end-stage renal disease, but the long-term success of peritoneal dialysis is limited. Both long-term CAPD and episodes of peritonitis cause significant abnormalities in the morphology and function of the peritoneal membrane; the predominant changes are the development of peritoneal fibrosis and sclerosis. Previous studies have demonstrated that high glucose and hyperosmolar peritoneal dialysates can damage mesothelial cells both in vivo and in vitro (1,2,3,4,5,6,7,12,26,27,28,29). Thus, damage to mesothelial cells, which act as a selective permeability barrier to regulate the passage of water and solutes between the intravascular compartment and the peritoneal cavity, is considered to be the primary cause of peritoneal hyperpermeability and/or peritoneal fibrosis. However, the changes of intercellular junctions, which play an essential role in controlling permeability and in maintaining tissue organization, are poorly understood.

In the present study, we assessed the effects on HPMC of culture with glucose at 75 mM (1.35%), 140 mM (2.5%), and 222 mM (4.0%), which were the same concentrations as those in commercial peritoneal dialysates. In the presence of high glucose, we confirmed that there was a concentration-dependent decrease in cell proliferation, as has also been demonstrated in previous studies (17,18,19,20,21,29). We also assessed the effect of mannitol on cultured HPMC as an osmotic control. Even though a concentration-dependent decrease in cell proliferation was induced by mannitol, its effect was significantly weaker than that of glucose.

It has been reported that chronic exposure to dialysis fluid induces widening of the intercellular spaces between HPMC and detachment of these cells from the peritoneum (2,3,4,5). In the present study, we investigated the effects of high glucose on the intercellular junctions of HPMC. Immunostaining for ZO-1 and ß-catenin was linear and continuous along the cell contour in control cultures but became weaker and discontinuous in a concentration-dependent manner after culture with high glucose. Conversely, mannitol caused only a slight decrease of staining, with no discontinuity. Western blotting confirmed that high glucose decreased the levels of ZO-1, E-cadherin, and ß-catenin. Mannitol also decreased ZO-1 and ß-catenin, but the extent of the change was smaller.

It is generally believed that tight junctions can dynamically alter their structural and functional properties under different conditions and are subject to modulation by a variety of cellular and metabolic regulators (13,30,31,32,33,34). It has also been shown that the cadherin/catenin complex plays an important role in cell adhesion and signal transduction, as well as in initiation and maintenance of the structural and functional organization of cells and tissues (35,36,37,38,39). In the absence of functional catenins, adherens junctions do not form (37). The findings of the present study suggest that high glucose peritoneal dialysis fluid decreases the intercellular junctions of mesothelial cells and impairs their function, thus causing peritoneal hyperpermeability. The results of our cell proliferation, immunostaining, and Western blotting experiments demonstrated that the inhibitory effect of high glucose was not solely related to hyperosmolality but also to some property of glucose itself or its metabolic effects. Mannitol was less toxic than glucose in the present study, but the effects of metabolites of mannitol in humans are not well understood. In contrast, glucose is known to be safe, effective, cheap, and readily metabolized, so glucose is used clinically in dialysis fluids (40).

TGF-ß is a classical cytokine that plays a central role in regulating tissue repair and remodeling after injury, along with platelet-derived growth factor and basic fibroblast growth factor. Production and deposition of the extracellular matrix is an essential part of wound repair. TGF-ß is unique among the cytokines in stimulating matrix synthesis, inhibiting matrix degradation by proteases, and modulating matrix receptors to increase cell adhesion (41). In the present study, to investigate the mechanism behind the differing effects on cell proliferation and intercellular junctions of glucose and mannitol, we measured TGF-ß1 levels in the culture supernatant. A concentration-dependent increase of TGF-ß1 was observed with exposure of HPMC to glucose, so we also investigated the effects of TGF-ß1 on HPMC. We showed that cell proliferation, immunofluorescence for ZO-1 and ß-catenin, and the expression of ZO-1, ß-catenin, and E-cadherin were decreased in a TGF-ß1 concentration-dependent manner. Moreover, the present study showed that an anti—TGF-ß neutralizing antibody could inhibit the effects of both high glucose and TGF-ß1 on HPMC, although its inhibition of the actions of high glucose was weaker than its blocking effect on TGF-ß1.

These findings suggest that TGF-ß induced by high glucose inhibits mesothelial cell proliferation and causes damage to intercellular junctions. The difference in cytotoxicity between glucose and mannitol may be largely related to TGF-ß1. The anti—TGF-ß neutralizing antibody reversed these effects only partially, suggesting that peritoneal dialysate causes damage not only as a result of the effects of glucose and glucose-induced TGF-ß but also as a result of hyperosmolality per se.

In conclusion, the present study first clarified that (1) high glucose and TGF-ß caused damage to the intercellular junctions of HPMC (2), an anti—TGF-ß neutralizing antibody increased the expression of intercellular junctions, and (3) the effects of high glucose were caused not only by glucose itself but also by hyperosmolality and by glucose-induced TGF-ß1. Damage to the intercellular junctions of peritoneal mesothelial cells by a high glucose concentration in the dialysate may induce peritoneal hyperpermeability, mesothelial cell loss, and a progressive reduction in dialysis efficacy.


    Acknowledgments
 
This work was supported by the Baxter PD Fund.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Jörres A, Gahl GM, Frei U: Peritoneal dialysis fluid biocompatibility: Does it really matter? Kidney Int 46[Suppl 48]:S79 -S86, 1994
  2. Pollock CA, Ibels LS, Eckstein RP, Graham JC, Caterson RJ, Mahony JF, Ross Sheil AG: Peritoneal morphology on maintenance dialysis. Am J Nephrol 9:198 -204, 1989[Medline]
  3. Dobbie JW, Zaki M, Wilson L: Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis. Scott Med J 26:213 -223, 1981[Medline]
  4. Di Paolo N, Sacchi G, De Mia M, Gaggiotti E, Capotondo L, Rossi P, Bernini M, Pucci AM, Ibba L, Sabatelli P, Alessandrini C: Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 44:204 -211, 1986[Medline]
  5. Gotloib L, Shostack A, Bar-Sella P, Cohen R: Continuous mesothelial injury and regeneration during long term peritoneal dialysis. Perit Dial Bull 7:148 -155, 1987
  6. Dobbie JW: Morphology of the peritoneum in CAPD. Blood Purif 7: 74-85,1989[Medline]
  7. Dobbie JW, Lloyd JK, Gall CA: Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. Adv Perit Dial 6:3 -12, 1990[Medline]
  8. Gotch FA: Adequacy of peritoneal dialysis. Am J Kidney Dis 21: 96-98,1993[Medline]
  9. Quarello F, Bonello F, Boero R, Maffei S, Beltrame G, Belardi P, Scalzo B, Guarena C, Piccoli G, Piccoli G: CAPD in a large population: A 7-year experience. Adv Perit Dial5 : 56-62,1989[Medline]
  10. Nagy JA: Peritoneal membrane morphology and function. Kidney Int 56:S2 -S11, 1996
  11. Simionescu M, Simionescu N: Organization of cell junctions in the peritoneal mesothelium. J Cell Biol74 : 98-110,1977[Abstract/Free Full Text]
  12. Nagy JA, Jackman RW: Anatomy and physiology of the peritoneal membrane. Semin Dial 11:49 -56, 1998
  13. Schneeberger EE, Lynch RD: Structure, function, and regulation of cellular tight junctions. Am J Physiol262 : L647-L661,1992[Abstract/Free Full Text]
  14. Gabrielson EW, Gerwin BI, Harris CC, Roberts AB, Sporn MB, Lechner JF: Stimulation of DNA synthesis in cultured primary human mesothelial cells by specific growth factors. FASEB J2 : 2717-2721,1988[Abstract]
  15. Takazoe K, Nakayama M, Utsunomiya Y, Osaka N, Hayakawa H, Kubo H, Kawaguchi Y, Sakai O: Detection of TGF-ß1 in CAPD effluents. Clin Nephrol 47:67 -69, 1997[Medline]
  16. Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Klingler P, Grage B, Schmahl M, Knabbe C: Transforming growth factor-ß synthesis by human peritoneal mesothelial cells: Induction by interleukin-1. Am J Pathol 148:1679 -1688, 1996[Abstract]
  17. Yonekawa S: Effects of glucose and TGF-ß1 on the proliferation of cultured human peritoneal mesothelial cells [in Japanese]. Jpn J Nephrol 40:245 -251, 1998
  18. Kumano K, Schiller-Moran B, Hjelle JT, Moran JE: Effects of high glucose levels on cell proliferation and TGF- ß expression in cultured rat mesothelial cells. J Am Soc Nephrol4 : 410,1993
  19. Kumano K, Shimoda M, Hyodo T, Sakai T, Schiller B, Moran JE, Hjelle JT: TGF-ß suppresses peritoneal mesothelial cell growth and enhances fibronectin gene expression. J Am Soc Nephrol5 : 461,1994
  20. Kumano K, Shimoda M, Hyodo T, Sakai T: The role of TGF- ß in growth inhibition of peritoneal mesothelial cells in high-glucose dialysate. Perit Dial Int 15:S93 -S95, 1995
  21. Wang T, Chen YG, Ye RG, Li SL, Li HQ, Chen YX: Effect of glucose on TGF-ß1 expression in peritoneal mesothelial cells. Adv Perit Dial 11: 7-10,1995[Medline]
  22. Ikubo A, Morisaki T, Katano M, Kitsuki H, Anan K, Uchiyama A, Tanaka M, Torisu M: A possible role of TGF-ß in the formation of malignant effusions. Clin Immunol Immunopathol77 : 27-32,1995[Medline]
  23. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD: Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 37:1563 -1570, 1990[Medline]
  24. Takenouchi T, Munekata E: Trophic effects of substance P and ß-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells. Life Sci 56:PL479 -PL484, 1995[Medline]
  25. Gressner AM, Lahme B, Roth S: Attenuation of TGF- ß-induced apoptosis in primary cultures of hepatocytes by calpain inhibitors. Biochem Biophys Res Commun 231:457 -462, 1997[Medline]
  26. Breborowicz A, Rodela H, Oreopoulos DG: Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int41 : 1280-1285,1992[Medline]
  27. Slater ND, Cope GH, Raftery AT: Mesothelial hyperplasia in response to peritoneal dialysis fluid: A morphometric study in the rat. Nephron 58:466 -471, 1991[Medline]
  28. Gotloib L, Wajsbrot V, Shostak A, Kushnier R: Effect of hyperosmolality upon the mesothelial monolayer exposed in vivo and in situ to a mannitol-enriched dialysis solution. Nephron81 : 301-309,1999[Medline]
  29. Shao JC, Yorioka N, Nishida Y, Yamakido M: Effect of pH and glucose on cultured human peritoneal mesothelial cells. Scand J Urol Nephrol 33:248 -256, 1999[Medline]
  30. Balda MS, González-Mariscal L, Contreras RG, Macias-Silva M, Torres-Marquez ME, García-Sáinz JA, Cereijido M: Assembly and sealing of tight junctions: Possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin. J Membr Biol 122:193 -202, 1991[Medline]
  31. Balda MS, Gonzalez-Mariscal L, Matter K, Cereijido M, Anderson JM: Assembly of the tight junction: The role of diacylglycerol. J Cell Biol 123:293 -302, 1993[Abstract/Free Full Text]
  32. Citi S: The molecular organization of tight junctions. J Cell Biol 121:485 -489, 1993[Free Full Text]
  33. Nigam SK, Denisenko N, Rodriguez-Boulan E, Citi S: The role of phosphorylation in development of tight junctions in cultured renal epithelial (MDCK) cells. Biochem Biophys Res Commun181 : 548-553,1991[Medline]
  34. Singer KL, Stevenson BR, Woo PL, Firestone GL: Relationship of serine/threonine phosphorylation/dephosphorylation signaling to glucocorticoid regulation of tight junction permeability and ZO-1 distribution in nontransformed mammary epithelial cells. J Biol Chem269 : 16108-16115,1994[Abstract/Free Full Text]
  35. Takeichi M: The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development102 : 639-655,1988[Abstract/Free Full Text]
  36. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451 -1455, 1991[Abstract/Free Full Text]
  37. Gumbiner BM, McCrea PD: Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci17 : 155-158,1993[Abstract]
  38. Ozawa M, Ringwald M, Kemler R: Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA87 : 4246-4250,1990[Abstract/Free Full Text]
  39. Nagafuchi A, Takeichi M: Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J7 : 3679-3684,1988[Medline]
  40. Gokal R: Recent perspectives on peritoneal dialysis. Contrib Nephrol 102:98 -109, 1993[Medline]
  41. Roberts AB, McCune BK, Sporn MB: TGF-ß: Regulation of extracellular matrix. Kidney Int41 : 557-559,1992[Medline]
Received for publication November 6, 1999. Accepted for publication March 30, 2000.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
B. Balci-Peynircioglu, A. L. Waite, P. Schaner, Z. E. Taskiran, N. Richards, D. Orhan, S. Gucer, S. Ozen, D. Gumucio, and E. Yilmaz
Expression of ASC in Renal Tissues of Familial Mediterranean Fever Patients with Amyloidosis: Postulating a Role for ASC in AA Type Amyloid Deposition
Experimental Biology and Medicine, November 1, 2008; 233(11): 1324 - 1333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Endemann, H. Bergmeister, B. Bidmon, M. Boehm, D. Csaicsich, L. Malaga-Dieguez, K. Arbeiter, H. Regele, K. Herkner, and C. Aufricht
Evidence for HSP-mediated cytoskeletal stabilization in mesothelial cells during acute experimental peritoneal dialysis
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F47 - F56.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C.-L. Lin, J.-Y. Wang, Y.-T. Huang, Y.-H. Kuo, K. Surendran, and F.-S. Wang
Wnt/beta-Catenin Signaling Modulates Survival of High Glucose-Stressed Mesangial Cells
J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2812 - 2820.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Zareie, E. D. Keuning, P. M. ter Wee, C. G. Schalkwijk, R. H. J. Beelen, and J. van den Born
Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH
Nephrol. Dial. Transplant., January 1, 2006; 21(1): 208 - 216.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. C. K. Leung, L. Y. Y. Chan, F. F. K. Li, S. C. W. Tang, K. W. Chan, T. M. Chan, M. F. Lam, A. Wieslander, and K. N. Lai
Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF
Nephrol. Dial. Transplant., July 1, 2005; 20(7): 1336 - 1349.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Yung, X.-R. Chen, R. C. Tsang, Q. Zhang, and T. M. Chan
Reduction of Perlecan Synthesis and Induction of TGF-{beta}1 in Human Peritoneal Mesothelial Cells Due to High Dialysate Glucose Concentration: Implication in Peritoneal Dialysis
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1178 - 1188.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. Yanez-Mo, E. Lara-Pezzi, R. Selgas, M. Ramirez-Huesca, C. Dominguez-Jimenez, J. A. Jimenez-Heffernan, A. Aguilera, J. A. Sanchez-Tomero, M. A. Bajo, V. Alvarez, et al.
Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells
N. Engl. J. Med., January 30, 2003; 348(5): 403 - 413.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Ogata, N. Yorioka, and N. Kohno
Glucose and Prednisolone Alter Basic Fibroblast Growth Factor Expression in Peritoneal Mesothelial Cells and Fibroblasts
J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2787 - 2796.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ITO, T.
Right arrow Articles by YAMAKIDO, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ITO, T.
Right arrow Articles by YAMAKIDO, M.


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP